1-20 of 35
Richard M. Stone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax plus low intensity chemotherapy for adults with acute lymphoblastic leukemia

Clinical Trials & Observations
Marlise R. Luskin, Shai Shimony, Julia H. Keating, Eric S Winer, Jacqueline S. Garcia, Richard M. Stone, Elias J. Jabbour, Yael Flamand, Kristen Stevenson, Jeremy Adam Ryan, Zhihong Zeng, Anthony Letai, Marina Y. Konopleva, Nitin Jain, Daniel J DeAngelo
Journal: Blood Advances
Blood Adv bloodadvances.2024014405.
https://doi.org/10.1182/bloodadvances.2024014405
Published: 2024
Includes: Supplemental data
Journal Articles

Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1 -mutant AML

Jan Philipp Bewersdorf, Shai Shimony, Rory M. Shallis, Yiwen Liu, Guillaume Berton, Eva J. Schaefer, Amer M. Zeidan, Aaron D. Goldberg, Eytan M. Stein, Guido Marcucci, Rebecca P. Bystrom, R. Coleman Lindsley, Evan C. Chen, Jorge Ramos Perez, Anthony Stein, Vinod Pullarkat, Ibrahim Aldoss, Daniel J. DeAngelo, Donna S. Neuberg, Richard M. Stone, Sylvain Garciaz, Brian Ball, Maximilian Stahl
Journal: Blood Advances
Blood Adv (2024) 8 (18): 4845–4855.
https://doi.org/10.1182/bloodadvances.2024012858
Published: 2024
Includes: Supplemental data
Journal Articles

Tolerability & long-term disease control by IGHV mutation status among CLL patients on ibrutinib arm of E1912

Clinical Trials & Observations
Tait D. Shanafelt, Xin Victoria Wang, Curtis A. Hanson, Elisabeth Paietta, Susan M. O'Brien, M.D., Jacqueline Claudia Barrientos, Diane F Jelinek, Esteban Braggio, Jose F. Leis, cong zhang, Paul M. Barr, Amanda F Cashen, Anthony R Mato, Avina K Singh, Michael Mullane, Richard F. Little, Harry P. Erba, Richard M. Stone, Mark R Litzow, Martin S. Tallman, Neil E. Kay
Journal: Blood Advances
Blood Adv bloodadvances.2024013474.
https://doi.org/10.1182/bloodadvances.2024013474
Published: 2024
Includes: Supplemental data
Journal Articles

Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML

Clinical Trials & Observations
Jacqueline S. Garcia, Haesook T. Kim, H. Moses Murdock, Michela Ansuinelli, Jennifer Brock, Corey S. Cutler, Mahasweta Gooptu, Vincent T. Ho, John Koreth, Sarah Nikiforow, Rizwan Romee, Roman Shapiro, Daniel J. DeAngelo, Richard M. Stone, Denbaa Bat-Erdene, Jeremy Ryan, Manuel E. Contreras, Geoffrey Fell, Anthony Letai, Jerome Ritz, R. Coleman Lindsley, Robert J. Soiffer, Joseph H. Antin
Journal: Blood Advances
Blood Adv (2024) 8 (4): 978–990.
https://doi.org/10.1182/bloodadvances.2023012120
Published: 2024
Includes: Supplemental data
Journal Articles

Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia

Clinical Trials & Observations
Andrew A. Lane, Jacqueline S. Garcia, Evangeline G. Raulston, Jada L. Garzon, Ilene Galinsky, Emilie W. Baxter, Rebecca Leonard, Daniel J. DeAngelo, Marlise R. Luskin, Christopher R. Reilly, Maximilian Stahl, Richard M. Stone, Rahul S. Vedula, Martha M. Wadleigh, Eric S. Winer, Tariq Mughal, Christopher Brooks, Ira V. Gupta, Kristen E. Stevenson, Donna S. Neuberg, Siyang Ren, Julia Keating, Marina Konopleva, Anthony Stein, Naveen Pemmaraju
Journal: Blood Advances
Blood Adv (2024) 8 (3): 591–602.
https://doi.org/10.1182/bloodadvances.2023011721
Published: 2024
Includes: Supplemental data
Journal Articles

Updating the American Society of Hematology guidelines for treating older adults with acute myeloid leukemia

Clinical Trials & Observations
Richard M. Stone, Jessica K. Altman, Mikkael A. Sekeres
Journal: Blood Advances
Blood Adv (2023) 7 (24): 7457–7458.
https://doi.org/10.1182/bloodadvances.2023009696
Published: 2023
Journal Articles

FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years

Clinical Trials & Observations
Shai Shimony, Geoffrey Fell, Evan C. Chen, Harrison K. Tsai, Martha Wadleigh, Eric S. Winer, Jacqueline S. Garcia, Marlise R. Luskin, Maximilian Stahl, Donna S. Neuberg, Daniel J. DeAngelo, R. Coleman Lindsley, Richard M. Stone
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5354–5358.
https://doi.org/10.1182/bloodadvances.2023009748
Published: 2023
Includes: Supplemental data
Journal Articles

Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials

Clinical Trials & Observations
Shai Shimony, Yael Flamand, Yannis K. Valtis, Andrew E. Place, Lewis B. Silverman, Lynda M. Vrooman, Andrew M. Brunner, Stephen E. Sallan, Richard M. Stone, Martha Wadleigh, Donna S. Neuberg, Daniel J. DeAngelo, Marlise R. Luskin
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5234–5245.
https://doi.org/10.1182/bloodadvances.2023009976
Published: 2023
Includes: Supplemental data
Journal Articles

Association of social deprivation with survival in younger adult patients with AML: an Alliance study

Clinical Trials & Observations
Melanie Rebechi, Jessica Kohlschmidt, Krzysztof Mrózek, Deedra Nicolet, Alice S. Mims, James S. Blachly, Shelley Orwick, Karilyn T. Larkin, Christopher C. Oakes, Andrew Hantel, Andrew J. Carroll, William G. Blum, Bayard L. Powell, Geoffrey L. Uy, Richard M. Stone, Richard A. Larson, John C. Byrd, Electra D. Paskett, Jesse J. Plascak, Ann-Kathrin Eisfeld
Journal: Blood Advances
Blood Adv (2023) 7 (15): 4019–4023.
https://doi.org/10.1182/bloodadvances.2022009325
Published: 2023
Includes: Supplemental data
Journal Articles

Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph + acute lymphoblastic leukemia

Clinical Trials & Observations
Anjali S. Advani, Anna Moseley, Kristen M. O’Dwyer, Brent L. Wood, Jae Park, Matthew Wieduwilt, Deepa Jeyakumar, George Yaghmour, Ehab L. Atallah, Aaron T. Gerds, Susan M. O'Brien, Jane L. Liesveld, Megan Othus, Mark Litzow, Richard M. Stone, Elad Sharon, Harry P. Erba
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1279–1285.
https://doi.org/10.1182/bloodadvances.2022008216
Published: 2023
Includes: Supplemental data
Journal Articles

Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia

Clinical Trials & Observations
Shai Shimony, Yiwen Liu, Yannis K. Valtis, Jonathan D. Paolino, Andrew E. Place, Andrew M. Brunner, Lachelle D. Weeks, Lewis B. Silverman, Lynda M. Vrooman, Donna S. Neuberg, Richard M. Stone, Daniel J. DeAngelo, Marlise R. Luskin
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1092–1102.
https://doi.org/10.1182/bloodadvances.2022008280
Published: 2023
Includes: Supplemental data
Journal Articles

The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study

Clinical Trials & Observations
Ibrahim Aldoss, Jun Yin, Anna Wall, Krzysztof Mrózek, Michaela Liedtke, David F. Claxton, Matthew C. Foster, Frederick R. Appelbaum, Harry P. Erba, Mark R. Litzow, Martin S. Tallman, Richard M. Stone, Richard A. Larson, Anjali S. Advani, Wendy Stock, Selina M. Luger
Journal: Blood Advances
Blood Adv (2023) 7 (2): 196–204.
https://doi.org/10.1182/bloodadvances.2022007791
Published: 2023
Includes: Supplemental data
Journal Articles

High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML

Karilyn T. Larkin, Deedra Nicolet, Benjamin J. Kelly, Krzysztof Mrózek, Stephanie LaHaye, Katherine E. Miller, Saranga Wijeratne, Gregory Wheeler, Jessica Kohlschmidt, James S. Blachly, Alice S. Mims, Christopher J. Walker, Christopher C. Oakes, Shelley Orwick, Isaiah Boateng, Jill Buss, Adrienne Heyrosa, Helee Desai, Andrew J. Carroll, William Blum, Bayard L. Powell, Jonathan E. Kolitz, Joseph O. Moore, Robert J. Mayer, Richard A. Larson, Richard M. Stone, Electra D. Paskett, John C. Byrd, Elaine R. Mardis, Ann-Kathrin Eisfeld
Journal: Blood Advances
Blood Adv (2022) 6 (19): 5570–5581.
https://doi.org/10.1182/bloodadvances.2022007544
Published: 2022
Includes: Supplemental data
Journal Articles

Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia

Zachary D. Epstein-Peterson, Andriy Derkach, Susan Geyer, Krzysztof Mrózek, Jessica Kohlschmidt, Jae H. Park, Sridevi Rajeeve, Eytan M. Stein, Yanming Zhang, Harry Iland, Lynda J. Campbell, Richard A. Larson, Xavier Poiré, Bayard L. Powell, Wendy Stock, Richard M. Stone, Martin S. Tallman
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3433–3439.
https://doi.org/10.1182/bloodadvances.2021006682
Published: 2022
Journal Articles

Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy

Jurjen Versluis, Manu Pandey, Yael Flamand, J. Erika Haydu, Roger Belizaire, Mark Faber, Rahul S. Vedula, Anne Charles, Kevin M. Copson, Shai Shimony, Alon Rozental, Pavan K. Bendapudi, Ofir Wolach, Elizabeth A. Griffiths, James E. Thompson, Richard M. Stone, Daniel J. DeAngelo, Donna Neuberg, Marlise R. Luskin, Eunice S. Wang, R. Coleman Lindsley
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2835–2846.
https://doi.org/10.1182/bloodadvances.2021006166
Published: 2022
Includes: Supplemental data
Journal Articles

Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia

Clinical Trials & Observations
Sydney Fobare, Jessica Kohlschmidt, Hatice Gulcin Ozer, Krzysztof Mrózek, Deedra Nicolet, Alice S. Mims, Ramiro Garzon, James S. Blachly, Shelley Orwick, Andrew J. Carroll, Richard M. Stone, Eunice S. Wang, Jonathan E. Kolitz, Bayard L. Powell, Christopher C. Oakes, Ann-Kathrin Eisfeld, Erin Hertlein, John C. Byrd
Journal: Blood Advances
Blood Adv (2022) 6 (5): 1371–1380.
https://doi.org/10.1182/bloodadvances.2021006242
Published: 2022
Includes: Supplemental data
Journal Articles

t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity

Sarah B. Mueller, Paola Dal Cin, Long P. Le, Dora Dias-Santagata, Jochen K. Lennerz, A. John Iafrate, Hetal Desai Marble, Andrew M. Brunner, Matthew J. Weinstock, Marlise R. Luskin, Daniel J. De Angelo, Richard M. Stone, Valentina Nardi
Journal: Blood Advances
Blood Adv (2022) 6 (3): 818–827.
https://doi.org/10.1182/bloodadvances.2021005280
Published: 2022
Includes: Supplemental data
Journal Articles

Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active

Clinical Trials & Observations
Jacqueline S. Garcia, Haesook T. Kim, H. Moses Murdock, Corey S. Cutler, Jennifer Brock, Mahasweta Gooptu, Vincent T. Ho, John Koreth, Sarah Nikiforow, Rizwan Romee, Roman Shapiro, Fiona Loschi, Jeremy Ryan, Geoffrey Fell, Hannah Q. Karp, Fabienne Lucas, Annette S. Kim, Danielle Potter, Thelma Mashaka, Richard M. Stone, Daniel J. DeAngelo, Anthony Letai, R. Coleman Lindsley, Robert J. Soiffer, Joseph H. Antin
Journal: Blood Advances
Blood Adv (2021) 5 (24): 5536–5545.
https://doi.org/10.1182/bloodadvances.2021005566
Published: 2021
Includes: Supplemental data
Journal Articles

Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL

Clinical Trials & Observations
Matthew J. Wieduwilt, Jun Yin, Meir Wetzler, Geoffrey L. Uy, Bayard L. Powell, Jonathan E. Kolitz, Michaela Liedtke, Wendy Stock, Jan H. Beumer, Ryan J. Mattison, Elizabeth Storrick, Susan M. Christner, Lionel D. Lewis, Steven Devine, Richard M. Stone, Richard A. Larson
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4691–4700.
https://doi.org/10.1182/bloodadvances.2021004813
Published: 2021
Includes: Supplemental data
Journal Articles

Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)

Clinical Trials & Observations
Alison R. Walker, Guido Marcucci, Jun Yin, William Blum, Wendy Stock, Jessica Kohlschmidt, Krzysztof Mrózek, Andrew J. Carroll, Ann-Kathrin Eisfeld, Eunice S. Wang, Sawyer Jacobson, Jonathan E. Kolitz, Mohan Thakuri, Grerk Sutamtewagul, Ravi Vij, Robert K. Stuart, John C. Byrd, Clara D. Bloomfield, Richard M. Stone, Richard A. Larson
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2775–2787.
https://doi.org/10.1182/bloodadvances.2021004233
Published: 2021
Includes: Supplemental data